Result: $16.5 million settlement
Yarrington v. Solvay Pharmaceuticals, Inc.
In March 2010, the Court granted final approval to a $16.5 million settlement of a false advertising class action lawsuit against Solvay Pharmaceuticals. Lieff Cabraser served as Co-Lead Counsel, representing purchasers of Estratest – a hormone replacement drug.
The complaint alleged that Solvay deceptively marketed Estratest as an FDA-approved drug when in fact Estratest was not approved by the FDA. The settlement provided refunds to consumers for up to 30% of the purchase price paid for Estratest. In addition, $8 million of the settlement was allocated to fund programs and activities related to women’s health concerns at medical schools throughout the nation.
Civil Litigation News
Lieff Cabraser Announces Historic $235M Comprehensive Settlement with Altria in National JUUL Youth E-Cigarette Predatory Advertising, Addiction and Injury Cases
Unprecedented in scope, speed, and significance, the global settlement, reached just after plaintiffs concluded their case in the bellwether trial in San
Avery Halfon Named to Law360’s 2023 Consumer Protection Editorial Advisory Board
Law360 has selected Lieff Cabraser attorney Avery Halfon to serve as one of the lawyers on its 2023 Consumer Protection Editorial Advisory board.
Ex-JUUL COO Claims He Was Fired For Sharing Concerns About JUUL Targeting Teen Users
As reported by Law360 in its ongoing coverage of the JUUL multidistrict injury and predatory/fraudulent advertising litigation against Altria (formerly Philip Morris), extraordinary